Ireland - English - HPRA (Health Products Regulatory Authority)

intervet international bv - attenuated micronidia of trichophyton verrucosum strain ltf-130; attenuated micronidia of trichophyton verrucosum strain ltf-130; attenuated micronidia of trichophyton verrucosum strain ltf-130 - lyophilisate and solvent for suspension for injection - . - trichophyton - cattle - immunological

Ireland - English - HPRA (Health Products Regulatory Authority)

intervet ireland limited - attenuated micronidia of trichophyton verrucosum strain ltf-130; attenuated micronidia of trichophyton verrucosum strain ltf-130; attenuated micronidia of trichophyton verrucosum strain ltf-130 - lyophilisate and solvent for suspension for injection - . - trichophyton

Ireland - English - HPRA (Health Products Regulatory Authority)

intervet international bv - attenuated micronidia of trichophyton verrucosum strain ltf-130 - lyophilisate and solvent for suspension for injection - >9 and <21 - trichophyton vaccine - bovine - immunological

Ireland - English - HPRA (Health Products Regulatory Authority)

intervet ireland limited - trichophyton verrucosum strain ltf-130 - lyophilisate and solvent for suspension for injection - bovine - immunological - live vaccine

United States - English - NLM (National Library of Medicine)

allermed laboratories, inc. - trichophyton mentagrophytes (unii: 199i7j3jiv) (trichophyton mentagrophytes - unii:199i7j3jiv), trichophyton rubrum (unii: 2zau32517n) (trichophyton rubrum - unii:2zau32517n) - trichophyton mentagrophytes 1 g in 1000 ml - intradermal skin tests with trichophyton extract are indicated for use in persons who are suspected of having type i hypersensitivity (i.e. allergy) to the fungus. conditions under which the administration of allergenic extract may be contraindicated, depending upon individual circumstances, include: extreme sensitivity to an allergen - determined from the allergic history, or from previous anaphylaxis following skin testing or subcutaneous injection; myocardial infarction - patients who have experienced a recent myocardial infarction may be less able to tolerate the life-threatening effects of a serious adverse reaction. asthma - patients with highly unstable asthma are at greater risk of fatal reactions from skin tests than are patients without asthma, especially during seasonal exacerbations of the disease. also, the combination of unstable asthma and treatment with b-adrenergic blockers appears to increase this risk5 . allergenic extract should be temporarily withheld from patients if any of the followin

France - English - HMA (Heads of Medicines Agencies)

intervet deutschland gmbh - trichophyton verrucosum 7000000 iu/ml - powder and solvent for suspension for injection - cattle food - trichophyton vaccine

Slovenia - English - HMA (Heads of Medicines Agencies)

intervet deutschland gmbh - trichophyton verrucosum 7000000 iu/ml - powder and solvent for suspension for injection - cattle food - trichophyton vaccine

Germany - English - HMA (Heads of Medicines Agencies)

intervet deutschland gmbh - trichophyton verrucosum 7000000 iu/ml - powder and solvent for suspension for injection - cattle food - trichophyton vaccine

Greece - English - HMA (Heads of Medicines Agencies)

intervet deutschland gmbh - trichophyton verrucosum 7000000 iu/ml - powder and solvent for suspension for injection - cattle food - trichophyton vaccine

United Kingdom - English - VMD (Veterinary Medicines Directorate)

intervet international bv - trichophyton verrucosum - lyophilisate and solvent for suspension for injection - live fungal vaccine - cattle